29.05.2019 MeVis Medical Solutions AG  DE000A0LBFE4

DGAP-Adhoc: MeVis Medical Solutions AG: Application to change from Prime Standard to General Standard


 

DGAP-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Miscellaneous
MeVis Medical Solutions AG: Application to change from Prime Standard to General Standard

29-May-2019 / 17:55 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Bremen, May 29, 2019 - The shares of MeVis Medical Solutions AG, Bremen, [ISIN: DE000A0LBFE4], are currently admitted to trading on the regulated market of the Frankfurt Stock Exchange with simultaneous admission to the sub-segment of the regulated market of the Frankfurt Stock Exchange with additional post-admission obligations (Prime Standard).

The Executive Board of MeVis Medical Solutions AG decided today, with the approval of the Supervisory Board, to apply for the revocation of the admission to trading in the Prime Standard segment of the Frankfurt Stock Exchange. The change of the stock exchange segment will reduce the additional effort associated with the listing in the Prime Standard.

The revocation of the admission will become effective upon the expiration of a period of three months after the publication of the revocation decision by the Management Board of the Frankfurt Stock Exchange on the internet (www.deutsche-boerse.com). The revocation does not affect the admission of the shares of MeVis Medical Solutions AG to trading on the regulated market of the Frankfurt Stock Exchange (General Standard).

 

Contact:
Kirchhoff, Marcus / CEO

29-May-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: [email protected]
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 817411

 
End of Announcement DGAP News Service

817411  29-May-2019 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=817411&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 16,01 12,09 18,54 16,76 18,07 17,13 16,30
EBITDA1,2 6,41 5,25 9,18 7,60 8,25 5,97 5,30
EBITDA-Marge3 40,04 43,42 49,51 45,35 45,66 34,85 32,52
EBIT1,4 4,47 3,93 7,96 6,69 8,00 5,81 5,10
EBIT-Marge5 27,92 32,51 42,93 39,92 44,27 33,92 31,29
Jahresüberschuss1 6,74 3,43 5,62 7,17 8,07 5,70 4,40
Netto-Marge6 42,10 28,37 30,31 42,78 44,66 33,27 26,99
Cashflow1,7 6,58 3,51 7,32 5,52 6,55 2,89 3,40
Ergebnis je Aktie8 3,72 1,88 3,09 3,94 4,43 3,13 2,40
Dividende8 0,95 0,95 0,95 0,95 0,95 0,95 0,95
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
MeVis Med. Solutions
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0LBFE 32,000 Halten 58,24
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
13,91 10,25 1,36 12,14
KBV KCV KUV EV/EBITDA
3,27 20,15 3,40 9,45
Dividende '19 in € Dividende '20e in € Div.-Rendite '20e
in %
Hauptversammlung
0,95 0,95 2,97 24.03.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
- 27.05.2021 - 28.01.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-2,82% -2,04% 1,27% -1,84%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MeVis Medical Solutions AG  ISIN: DE000A0LBFE4 können Sie bei DGAP abrufen

Medtech , A0LBFE , M3V , XETR:M3V